With reference to letter dated 24th February 2021 intimating the details of the investor webinar which was scheduled today; Sanofi India has informed that the presentation made by the Company at the investor webinar is enclosed for reference under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.